HER2-positive Breast Cancer Clinical Trials in Amsterdam
2 recruitingAmsterdam, Netherlands
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Phase 1/1b Study of IAM1363 in HER2 Cancers
HER2-positive Breast CancerHER2 + Breast CancerHER2 Mutation-Related Tumors+10 more
Iambic Therapeutics, Inc243 enrolled45 locationsNCT06253871
Recruiting
Phase 2
Basket Study for Oligo-metastatic Breast Cancer
HER2-positive Breast Cancer
The Netherlands Cancer Institute72 enrolled1 locationNCT05982678